On Monday, Hersha Hospitality Trust (NYSE:HT)’s shares inclined 301.85% to $26.08.
Hersha Hospitality Trust (HT) owner of upscale hotels in urban gateway markets declared that the Company will release its financial results for the second quarter 2015 after the market close on Tuesday, July 28, 2015. The Company will host a conference call to talk about these results at 9:00 a.m. Eastern Time on Wednesday, July 29, 2015. Hosting the call will be Mr. Jay H. Shah, Chief Executive Officer, Mr. Neil H. Shah, President and Chief Operating Officer, and Mr. Ashish Parikh, Chief Financial Officer.
Hersha Hospitality Trust, a real estate investment trust, engages in the ownership and operation of mid scale limited service hotels in the Eastern United States. As of June 30, 2005, it owned interests in 35 hotels, counting 4 hotels owned through joint ventures in Pennsylvania, New York, New Jersey, Maryland, Georgia, Connecticut, and Massachusetts.
New York Community Bancorp, Inc. (NYSE:NYCB)’s shares gained 0.81% to $18.57.
In accordance with the Dodd-Frank Wall Street Reform and Consumer Protection Act (the “Dodd-Frank Act”) and the regulations promulgated thereunder by the Board of Governors of the Federal Reserve System (the “FRB”), New York Community Bancorp, Inc. (NYCB) (the “Company”) revealed the results of its 2015 Dodd-Frank Act company-run stress test (“DFAST”) under the Severely Adverse Scenario established by the FRB on October 23, 2014.
New York Community Bancorp, Inc. operates as a holding company for New York Community Bank and New York Commercial Bank that offer banking products and financial services in New York, New Jersey, Florida, Ohio, and Arizona. The company offers various deposit products that comprise checking and savings accounts, individual retirement accounts, certificates of deposit, NOW and money market accounts, and non-interest-bearing accounts.
At the end of Mondays trade, Provectus Biopharmaceuticals Inc (NYSEMKT:PVCT)‘s shares surged 3.19% to $0.640.
Provectus Biopharmaceuticals Inc (PVCT) declared that it has retained healthcare communications company PharmaHEALTHLabs to coordinate and facilitate an Investigator Advisory Board meeting to be held during 11th Brazilian Melanoma Conference from August 13-15, 2015 in Goiania, Brazil.
The meeting will target about 15 key oncologists who will be attending the conference and who are active in the investigator community in Brazil for the treatment of melanoma. The purpose is to offer insight and feedback into the status of treatment of melanoma in Brazil in addition to the feasibility of initiating the PV-10 Trial in Brazil.
Provectus Biopharmaceuticals, Inc., a development-stage biopharmaceutical company, engages in developing ethical pharmaceuticals for oncology and dermatology indications. Its product line comprises PV-10, which has accomplished Phase II study for metastatic melanoma; accomplished a Phase I study for breast cancer; and is in Phase I protocol expansion for liver metastasis, in addition to initiated a Phase I feasibility study to detect immune cell infiltration into melanomas.
Jumei International Holding Ltd (ADR) (NYSE:JMEI), ended its Monday’s trading session with -0.14% loss, and closed at $21.96.
Jumei International Holding Ltd (ADR) (JMEI) declared that it has attained a minority stake in It’S SKIN, a Korean beauty brand.
It’S SKIN is a prestige Korean beauty brand that has become very popular amongst Chinese consumers.
Mr. Leo Ou Chen, founder and CEO of Jumei, stated, The popularity of Korean beauty products in China has grown rapidly over the past few years. With an extensive catalogue of prestige products, It’S SKIN is an ideal partner for Jumei to collaborate with as we build Jumei Global into the largest cross border e-commerce platform in China. It’S SKIN will greatly benefit from the growing size and scale of our platform.
Jumei International Holding Limited operates as an online retailer of beauty products in the People’s Republic of China. The company offers beauty products, such as cosmetics, skin care, cosmetic applicators, fragrance, and body care products; and beauty products for men, and baby and children.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
